Monitoring the Signals: Making Remote Toxicity Management Work for Everyone

Lindsey Wahlstrom is a patient engagement strategist and advocate with more than a decade of experience bringing patient and caregiver perspectives into clinical research. Throughout her career, she has supported recruitment and engagement efforts for more than 230 clinical trials, with previous roles at PicnicHealth, Sano Genetics, Antidote Technologies, and Columbia University.

In 2023, Lindsey’s professional and personal worlds collided when her daughter, Rona, was diagnosed with a rare disease and later passed away from complications of treatment. As Rona’s stem cell donor, Lindsey participated in four clinical trials alongside her daughter, an experience that profoundly shaped her understanding of the burdens of research participation, the importance of quality of life, and the need to consider outcomes beyond traditional clinical measures. 

Today, Lindsey is the Co-Founder and Chief Momatologist of Rona’s FUN LAB, a nonprofit dedicated to improving quality of life for critically ill children and their families. She also consults with organizations across healthcare and life sciences to develop more patient-centered engagement strategies. Her work focuses on bridging the gap between innovation and real-world experience, ensuring that advances in research and technology deliver meaningful value to patients, caregivers, and the sites that support them. 

Jill Bell is Chief Science Officer at Evinova. She brings more than 20 years of scientific experience spanning academia and industry, with deep expertise in the design and delivery of end-to-end evidence generation strategies that support clinical benefit demonstration and treatment value propositions. Dr. Bell is a recognized leader in measurement science and endpoints, patient-centered drug development, and the strategic integration of scientific innovation and digital solutions in clinical trials.
 
In her current role, Dr. Bell leads an omni-disciplinary team that applies expertise in measurement science, behavioral science, and quantitative analytics to advance innovative digital health applications across both clinical trial and care settings — ensuring that Evinova's products are grounded in the scientific rigor needed to augment clinical submissions, improve patient outcomes, and support evidence-based decisions.
 
Dr. Bell has broad therapeutic area experience and a strong track record in end-to-end clinical development. She regularly disseminates scientific insights through publications, conferences, and multidisciplinary collaborations, contributing to informed decision-making across drug development and helping transform the experiences of patients, caregivers, and clinical teams.

Chad Leaver is Senior Director, Business Planning & Operations in Evinova's Science organization, where he serves as Chief of Staff to the Chief Science Officer. An epidemiologist by training, Chad has spent more than 20 years working across healthcare, government, academia, and industry. His work has helped advance the clinical adoption of digital health technologies and informed policies that support patient access to innovative medicines. Chad is a published author and leukemia survivor who brings both professional expertise and lived experience to discussions on scientific innovation, digital health, and patient-centered healthcare.

Alisha has over 20 years of hands-on patient experience in the clinical research industry. She started her career as site coordinator and then progressed into management roles across all clinical study phases and multiple therapeutic areas, with a specific focus on Women's health.

Alisha has worked in a variety of site settings, including non-profits, private practices, hospitals, and integrated research organizations, where she established Elligo's first Women's health sites in Austin, Texas. In 2020, Alisha supported the landmark Moderna vaccine trials in Laredo, Texas, and most recently served as the North American team lead on Medables Site Success Team where she assisted sites with new technology, as well as bringing the voice of sites into the development, implementation and adoption of new technology. Alisha received her degree from San Francisco State University.